Matches in SemOpenAlex for { <https://semopenalex.org/work/W2282026089> ?p ?o ?g. }
- W2282026089 endingPage "87" @default.
- W2282026089 startingPage "74" @default.
- W2282026089 abstract "Cytotoxic chemotherapy remains central to the treatment of all subtypes of metastatic breast cancer (MBC). We review evidence-based chemotherapy options for women with MBC after an anthracycline and a taxane including re-challenge with anthracycline or taxane, capecitabine, eribulin and ixabepilone as a single agent or combination with capecitabine (not approved in the EU); and the vinca alkaloid vinflunine as single agent or combined with either capecitabine/gemcitabine (also not approved EU or USA). Etirinotecan pegol, comprising irinotecan bound to polyethylene glycol by a biodegradable linker, is a new cytotoxic agent for patients with MBC that has achieved encouraging response rates in phase II studies; it has been further evaluated in the phase III BEACON trial. New cytotoxics should address novel targets or modes of delivery, achieve meaningful improvements in outcomes and seek to identify predictive biomarker(s)." @default.
- W2282026089 created "2016-06-24" @default.
- W2282026089 creator A5010064853 @default.
- W2282026089 creator A5073796630 @default.
- W2282026089 creator A5079489429 @default.
- W2282026089 creator A5089518617 @default.
- W2282026089 date "2016-04-01" @default.
- W2282026089 modified "2023-09-26" @default.
- W2282026089 title "Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer" @default.
- W2282026089 cites W1526433935 @default.
- W2282026089 cites W1796787464 @default.
- W2282026089 cites W1854510938 @default.
- W2282026089 cites W1885306047 @default.
- W2282026089 cites W1905765735 @default.
- W2282026089 cites W1939003096 @default.
- W2282026089 cites W1946759281 @default.
- W2282026089 cites W1966574632 @default.
- W2282026089 cites W1970168920 @default.
- W2282026089 cites W1979080372 @default.
- W2282026089 cites W1995809342 @default.
- W2282026089 cites W2002950604 @default.
- W2282026089 cites W2007158936 @default.
- W2282026089 cites W2010113256 @default.
- W2282026089 cites W2015294539 @default.
- W2282026089 cites W2021116311 @default.
- W2282026089 cites W2034817135 @default.
- W2282026089 cites W2038716828 @default.
- W2282026089 cites W2039310969 @default.
- W2282026089 cites W2059393966 @default.
- W2282026089 cites W2061860268 @default.
- W2282026089 cites W2062954993 @default.
- W2282026089 cites W2064087555 @default.
- W2282026089 cites W2067357376 @default.
- W2282026089 cites W2071391095 @default.
- W2282026089 cites W2072735451 @default.
- W2282026089 cites W2074890479 @default.
- W2282026089 cites W2095832858 @default.
- W2282026089 cites W2099658604 @default.
- W2282026089 cites W2100749093 @default.
- W2282026089 cites W2102838762 @default.
- W2282026089 cites W2105496345 @default.
- W2282026089 cites W2106955083 @default.
- W2282026089 cites W2111495238 @default.
- W2282026089 cites W2112055293 @default.
- W2282026089 cites W2114159573 @default.
- W2282026089 cites W2115298175 @default.
- W2282026089 cites W2116144791 @default.
- W2282026089 cites W2116760308 @default.
- W2282026089 cites W2119974083 @default.
- W2282026089 cites W2120627364 @default.
- W2282026089 cites W2121356187 @default.
- W2282026089 cites W2121920731 @default.
- W2282026089 cites W2123732467 @default.
- W2282026089 cites W2127152525 @default.
- W2282026089 cites W2131770017 @default.
- W2282026089 cites W2133198629 @default.
- W2282026089 cites W2135601011 @default.
- W2282026089 cites W2136451551 @default.
- W2282026089 cites W2137228442 @default.
- W2282026089 cites W2137545466 @default.
- W2282026089 cites W2138941973 @default.
- W2282026089 cites W2138997964 @default.
- W2282026089 cites W2140837341 @default.
- W2282026089 cites W2141257680 @default.
- W2282026089 cites W2143399650 @default.
- W2282026089 cites W2150296977 @default.
- W2282026089 cites W2153017356 @default.
- W2282026089 cites W2154908899 @default.
- W2282026089 cites W2157354264 @default.
- W2282026089 cites W2157470118 @default.
- W2282026089 cites W2158891743 @default.
- W2282026089 cites W2160709317 @default.
- W2282026089 cites W2167188058 @default.
- W2282026089 cites W2167224460 @default.
- W2282026089 cites W2175453042 @default.
- W2282026089 cites W2225859372 @default.
- W2282026089 cites W2228100121 @default.
- W2282026089 cites W2471690942 @default.
- W2282026089 cites W2526703400 @default.
- W2282026089 cites W2596678026 @default.
- W2282026089 cites W2604222719 @default.
- W2282026089 cites W2740335290 @default.
- W2282026089 cites W4234394290 @default.
- W2282026089 doi "https://doi.org/10.1016/j.critrevonc.2016.01.021" @default.
- W2282026089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26857987" @default.
- W2282026089 hasPublicationYear "2016" @default.
- W2282026089 type Work @default.
- W2282026089 sameAs 2282026089 @default.
- W2282026089 citedByCount "63" @default.
- W2282026089 countsByYear W22820260892016 @default.
- W2282026089 countsByYear W22820260892017 @default.
- W2282026089 countsByYear W22820260892018 @default.
- W2282026089 countsByYear W22820260892019 @default.
- W2282026089 countsByYear W22820260892020 @default.
- W2282026089 countsByYear W22820260892021 @default.
- W2282026089 countsByYear W22820260892022 @default.
- W2282026089 countsByYear W22820260892023 @default.
- W2282026089 crossrefType "journal-article" @default.